secwatch / observer
8-K filed April 29, 2026, 7:59 PM ET ticker RVYL CIK 0001419275
regulatory confidence medium sentiment negative materiality 0.80

RYVYL receives Nasdaq delisting notice for equity non-compliance; merger expected to cure

RYVYL Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001185185-26-001602
form_type
8-K
ticker
RVYL
cik
0001419275
company_name
RYVYL Inc.
filed_at
2026-04-29T23:59:59+00:00
discovered_at
2026-05-14T18:02:32.259954+00:00
generated_at
2026-05-15T01:40:30.455610+00:00
sec_items
["3.01", "9.01"]
event_type
regulatory
sentiment
negative
materiality_score
0.8
calibrated_materiality_score
0.8
confidence
medium
secwatch_canonical_url
https://secwatch.observer/filing/0001185185-26-001602
json_url
https://secwatch.observer/filing/0001185185-26-001602.json
markdown_url
https://secwatch.observer/filing/0001185185-26-001602.md
text_url
https://secwatch.observer/filing/0001185185-26-001602.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1419275/000118518526001602/0001185185-26-001602-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1419275/000118518526001602/rvyl8k042926.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

2bea65caf1c954f503d2ede1fc36b311d0bb7084

RYVYL Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

SEC 8-K Item 3.01 confidence 0.9 SEC evidence

Comparable filings

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

Comparable filing

May 27, 2026, Actinium Pharmaceuticals, Inc. (the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating that the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”), which requires a listed company to maintain stockholders’ equity of $4.0 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31, 2026, the Company reported stockholders’ equity of approximately

Filing page SEC filing

CSAI

Cloudastructure receives Nasdaq delinquency notice for late Q1 10-Q filing

CLOUDASTRUCTURE, INC. May 29, 2026, 5:09 PM ET regulatory Items 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

Comparable filing

May 26, 2026, Cloudastructure, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (“Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Company requires additional time to review and confirm the accounting treatment for its outstand

Filing page SEC filing

GURE

Gulf Resources receives Nasdaq delisting notice for late Q1 2026 10-Q filing

GULF RESOURCES, INC. May 29, 2026, 4:45 PM ET regulatory Items 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

Comparable filing

May 26, 2026, Gulf Resources (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), indicating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”), and the Company remains delinquent in filing its annual report on Form 10-K for the year ended December 31, 2025 (the “Initial Delinquent Filing”), the Company is in non-compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing all required periodic financial reports wit

Filing page SEC filing

ONFO

Onfolio receives Nasdaq delisting notice for insufficient equity ($1.22M vs $2.5M min)

Onfolio Holdings, Inc May 29, 2026, 4:30 PM ET regulatory Items 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

Comparable filing

May 26, 2026, Onfolio Holdings Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) informing the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice states that the Company’s Quarterly Report on Form 10-Q for the for the period ended March 31, 2026 reported stockholders’ equity of $1,216,603. As of the date of the Notice

Filing page SEC filing

RR

Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing

RICHTECH ROBOTICS INC. May 28, 2026, 4:49 PM ET regulatory Items 3.01, 8.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

Comparable filing

May 22, 2026, Richtech Robotics Inc., a Nevada corporation (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), because it has not timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “ Form 10-Q ”) with the U.S. Securities and Exchange Commission (the “ SEC ”). The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Com

Filing page SEC filing

CDT

CDT Equity receives Nasdaq deficiency letter for late Q1 10-Q filing; has until July 20 to submit plan

CDT Equity Inc. May 28, 2026, 4:30 PM ET regulatory Items 3.01, 7.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

Comparable filing

May 21, 2026, CDT Equity Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Requirement”) because the Company did not file its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2026 (the “Form 10-Q”) in a timely manner, as required for continued listing on The Nasdaq Capital Market. The Notice has no immediate effect on the listing or trading of the Company’s

Filing page SEC filing

CHAR

Charlton Aria receives Nasdaq delinquency notice for untimely Q1 10-Q filing

Charlton Aria Acquisition Corp May 27, 2026, 4:41 PM ET regulatory Items 3.01, 7.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

Comparable filing

May 22, 2026, Charlton Aria Acquisition Corporation (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that

Filing page SEC filing

SONM

DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider

DNA X, Inc. May 27, 2026, 4:35 PM ET regulatory Items 1.01, 2.03, 3.01, 3.02, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 23, 2026, the Company received written notice (“Notice”) regarding non-compliance of the minimum stockholders’ equity requirement of $2.5 Million for continued listing on Nasdaq Capital Market under Rule 5550(b)(1)

Comparable filing

May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests a hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting

Filing page SEC filing

Source: SEC EDGAR
accession 0001185185-26-001602

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.